Schedule 13G ownership disclosure
CYMABAY THERAPEUTICS INC
Security class unavailable · CUSIP: 23257D103
Event date: 2020-05-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,449,612
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-070289
- Form type
- SC 13G
- Filer
- CymaBay Therapeutics, Inc.
- CIK
- CIK 1042074
- Filed
- Jun 05, 2020
- Reporting period
- May 26, 2020
- Description
- Schedule 13G beneficial ownership